C. Seigner et al., CLINICAL INTEREST OF HYDROPHOBIC FORMS OF SERUM CARCINOEMBRYONIC ANTIGEN (CEA) MEASUREMENT IN METASTATIC COLON-CANCER, Bulletin du cancer, 82(4), 1995, pp. 303-308
Thirty-four patients with metastatic colon cancer were treated with fl
uorouracile and folinic acid. The follow-up of disease was evaluated b
y tomodensitometric CT-scan analysis and by serum CEA determination. I
n addition, a study of the different CEA molecular forms separated by
Triton X114 partitioning immunoprecipitation and immunoblotting was co
mpleted Concerning the aqueous phase, no relationship appeared between
the pattern of CEA species and the outcome of chemotherapy. Opposingl
y, the analysis of the hydrophobic phase gave results closely correlat
ed to chemotherapeutic response. In 19/34 patients, the hydrophobic CE
A forms were absent or weakly expressed; out of these patients, 16/19
underwent a successful response to chemotherapy regimen. Opposingly al
l of the remaining 15 patients expressing high levels of hydrophobic C
EA species were non-responders The present study thus gives new means
for predicting the outcome of 5 fluorouracile-folinic acid chemotherap
y by screening the molecular CEA forms expressed in the serum of patie
nts with metastatic colon cancer.